TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 45 filers reported holding TG THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,504,000 | -39.0% | 968,608 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $7,384,000 | +35.4% | 953,952 | +6.0% | 0.00% | 0.0% |
| Q2 2016 | $5,452,000 | -31.0% | 899,739 | -2.9% | 0.00% | 0.0% |
| Q1 2016 | $7,896,000 | -26.2% | 926,707 | +3.3% | 0.00% | -50.0% |
| Q4 2015 | $10,699,000 | +22.3% | 896,809 | +3.3% | 0.00% | 0.0% |
| Q3 2015 | $8,750,000 | -29.0% | 868,096 | +16.8% | 0.00% | 0.0% |
| Q2 2015 | $12,328,000 | +8.6% | 743,106 | +1.3% | 0.00% | 0.0% |
| Q1 2015 | $11,356,000 | +39.4% | 733,602 | +42.6% | 0.00% | +100.0% |
| Q4 2014 | $8,149,000 | +238.3% | 514,441 | +127.9% | 0.00% | – |
| Q3 2014 | $2,409,000 | +5.1% | 225,742 | -7.6% | 0.00% | – |
| Q2 2014 | $2,293,000 | +98.4% | 244,195 | +45.7% | 0.00% | – |
| Q1 2014 | $1,156,000 | +116.1% | 167,583 | +22.1% | 0.00% | – |
| Q4 2013 | $535,000 | -35.0% | 137,263 | -15.9% | 0.00% | – |
| Q3 2013 | $823,000 | +2.9% | 163,232 | +30.4% | 0.00% | – |
| Q2 2013 | $800,000 | – | 125,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |